glp 1 autophagy Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist Several modulator molecules linked to

The study reported that participants "regained two-thirds of their prior weight loss." A meaningful share of the loss is muscle: across body-composition studies, roughly a quarter of the weight lost is lean mass (muscle), with the rest fat (Karakasis and colleagues, network meta-analysis, Metabolism , 2024), and the honest range landing between about 15% and 40% (Hierholzer and colleagues, review, 2026)

Keep taking it and the effect holds

J Clin Endocrinol Metab 98:290298

However, their safety and efficacy depend on various factors, including age, underlying health conditions, and the quality of medical care

10.1038/s41419-019-1327-5 116 MantelP.-Y.Schmidt-WeberC